Latest Breaking News On - ப்ரொஃபெஸர் ஆஃப் மருந்து இல் ஸ்டான்போர்ட் பல்கலைக்கழகம் - Page 3 : comparemela.com
Watch Live: Gov DeSantis Holds Public Health Roundtable with Renowned Doctors and Epidemiologists
breitbart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from breitbart.com Daily Mail and Mail on Sunday newspapers.
Fact-checking claims made by experts brought in by DeSantis to analyze COVID response
news4jax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news4jax.com Daily Mail and Mail on Sunday newspapers.
Alone, lonely, and missed
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN DIEGO, Feb. 16, 2021 /PRNewswire/ Prometheus Biosciences, Inc. ( Prometheus ), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD), today announced the appointments of Judith L. Swain, MD and Helen C. Adams to its board of directors. Ms. Adams will assume the position of Chair of the Audit Committee. We re thrilled to have Judith and Helen join our Board of Directors, who bring significant clinical medicine and financial expertise that will be important as we advance our pipeline to people living with IBD, said Mark McKenna, President and CEO of Prometheus. Judith is a distinguished physician scientist and veteran scientific advisory board member with an international perspective on drug development. Helen is an outstanding financial professional and exper
Share this article
Share this article
SAN JOSE, Calif., Feb. 10, 2021 /PRNewswire/ Visby Medical™ announced today the US Food and Drug Administration (FDA) authorized Visby s rapid PCR COVID-19 test for use at the point of care (POC). Building on the FDA s emergency use authorization granted earlier this year, Visby Medical s rapid PCR COVID-19 test may now be used by any organization with a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver.
Visby Medical Test - Now Authorized for CLIA-Waived Settings
It is imperative that the best tools are available to fight infection, protect the most vulnerable and maintain essential operations. PCR testing has been acknowledged as the gold standard for its high level of accuracy, but has drawbacks including the reliance on centralized labs and long wait times for results.